| Full Name | Amit Panwalkar |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 25 Years |
| Location | 820 4th St N, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043426034 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 23682 (Nebraska) | Primary |
| 207RH0003X | Internal Medicine - Hematology & Oncology | 10919 (North Dakota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Sanford Medical Center Thief River Falls | Thief river falls, MN | Hospital |
| Kittson Memorial Hospital | Hallock, MN | Hospital |
| Perham Health | Perham, MN | Hospital |
| Sanford Mayville | Mayville, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
Genta Incorporated today announced preliminary results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine (DTIC) administered with or without Genasense® in patients who have not previously received chemotherapy.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.
About one decade after its first benefit assessment of negative pressure wound therapy, the German Institute for Quality and Efficiency in Health Care is reassessing this treatment method. However, then as now, its benefit and harm are unclear.
Researchers at Kessler Foundation and Rutgers University correlated neuroimaging data with reading deficits in patients with subacute left hemispheric stroke. Their findings add to our knowledge of the neural mechanisms of reading and may be useful in the development of reading interventions that address specific neurological deficits.
› Verified 2 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
Genta Incorporated today announced preliminary results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine (DTIC) administered with or without Genasense® in patients who have not previously received chemotherapy.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.
About one decade after its first benefit assessment of negative pressure wound therapy, the German Institute for Quality and Efficiency in Health Care is reassessing this treatment method. However, then as now, its benefit and harm are unclear.
Researchers at Kessler Foundation and Rutgers University correlated neuroimaging data with reading deficits in patients with subacute left hemispheric stroke. Their findings add to our knowledge of the neural mechanisms of reading and may be useful in the development of reading interventions that address specific neurological deficits.
› Verified 2 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
Genta Incorporated today announced preliminary results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine (DTIC) administered with or without Genasense® in patients who have not previously received chemotherapy.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.
About one decade after its first benefit assessment of negative pressure wound therapy, the German Institute for Quality and Efficiency in Health Care is reassessing this treatment method. However, then as now, its benefit and harm are unclear.
Researchers at Kessler Foundation and Rutgers University correlated neuroimaging data with reading deficits in patients with subacute left hemispheric stroke. Their findings add to our knowledge of the neural mechanisms of reading and may be useful in the development of reading interventions that address specific neurological deficits.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amit Panwalkar, 820 4th St N, Fargo, ND 58102-4539 Ph: (701) 234-6161 | Amit Panwalkar, 820 4th St N, Fargo, ND 58102-4539 Ph: (701) 234-6161 |
News Archive
Genta Incorporated today announced preliminary results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine (DTIC) administered with or without Genasense® in patients who have not previously received chemotherapy.
Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.
Apollo Health Street, a developer of world-class solutions that tackle healthcare's toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.
About one decade after its first benefit assessment of negative pressure wound therapy, the German Institute for Quality and Efficiency in Health Care is reassessing this treatment method. However, then as now, its benefit and harm are unclear.
Researchers at Kessler Foundation and Rutgers University correlated neuroimaging data with reading deficits in patients with subacute left hemispheric stroke. Their findings add to our knowledge of the neural mechanisms of reading and may be useful in the development of reading interventions that address specific neurological deficits.
› Verified 2 days ago
Dr. Keri Lynn Crewson, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Sanford Health, 801 Broadway North, Fargo, ND 58122 Phone: 701-234-5933 Fax: 701-234-7230 | |
Abdallah M Mansour, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8900 | |
Derek Anderson, DO Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-234-5933 | |
Gerald G Gross, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 820 4th St N, Fargo, ND 58102 Phone: 701-234-6161 | |
Paul James Carson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-4811 Fax: 701-234-6979 | |
Howard L Russell, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 820 N 4th St, Fargo, ND 58122 Phone: 701-234-6161 Fax: 701-234-3861 | |
Dr. Emuejevoke Joseph Okoh, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 |